I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 12 studies | 31% ± 19% | |
| endothelial cell | 10 studies | 33% ± 10% | |
| macrophage | 7 studies | 26% ± 12% | |
| adipocyte | 6 studies | 34% ± 6% | |
| ciliated cell | 6 studies | 30% ± 12% | |
| type II pneumocyte | 6 studies | 47% ± 10% | |
| smooth muscle cell | 6 studies | 33% ± 13% | |
| monocyte | 6 studies | 33% ± 13% | |
| hepatocyte | 5 studies | 62% ± 24% | |
| pericyte | 5 studies | 28% ± 13% | |
| fibroblast | 5 studies | 24% ± 5% | |
| T cell | 5 studies | 24% ± 7% | |
| alveolar macrophage | 5 studies | 54% ± 27% | |
| type I pneumocyte | 5 studies | 29% ± 5% | |
| ionocyte | 3 studies | 33% ± 5% | |
| classical monocyte | 3 studies | 18% ± 0% | |
| myeloid cell | 3 studies | 31% ± 18% | |
| ependymal cell | 3 studies | 46% ± 18% | |
| club cell | 3 studies | 35% ± 10% | |
| natural killer cell | 3 studies | 25% ± 6% | |
| lymphocyte | 3 studies | 31% ± 6% | |
| renal alpha-intercalated cell | 3 studies | 63% ± 27% |
